Analysts have been eager to weigh in on the Healthcare sector with new ratings on Tenet Healthcare (THC) and Adamis Pharma (ADMP).
Tenet Healthcare (THC)
In a report released today, John Ransom from Raymond James reiterated a Buy rating on Tenet Healthcare, with a price target of $85.00. The company’s shares closed last Tuesday at $63.42, close to its 52-week high of $67.85.
According to TipRanks.com, Ransom is a 5-star analyst with an average return of 14.5% and a 64.8% success rate. Ransom covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Alignment Healthcare, and Acadia Healthcare.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Tenet Healthcare with a $72.00 average price target.
See today’s analyst top recommended stocks >>
Adamis Pharma (ADMP)
Raymond James analyst Elliot Wilbur maintained a Hold rating on Adamis Pharma today. The company’s shares closed last Tuesday at $0.67, close to its 52-week low of $0.38.
According to TipRanks.com, Wilbur has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -2.7% and a 43.7% success rate. Wilbur covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, Amneal Pharmaceuticals, and Flexion Therapeutics.
The the analyst consensus on Adamis Pharma is currently a Hold rating.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
